復興亞洲(00274.HK):延遲發佈截至2024年3月31日止十五個月的年度業績公吿
格隆匯7月16日丨復興亞洲(00274.HK)公佈,由於新收購子公司的部分資訊和文件(包括銀行及審計確認函、估值報吿和其他財務資訊)仍未落實,有關截至2024年3月31日止十五個月的經審核末期業績("二零2024年年度業績")公吿將延遲發佈。因此,公司需要額外的時間編制2024年年度業績。公司正在與核數師緊密合作,為核數師提供所有必要的資訊和文件,以儘快完成審計程序。
於公吿日期,公司仍在準備必要的資訊和文件,因此公司需要更多時間來完成2024年年度業績。
預計2024年年度業績公吿將於2024年7月26日(星期五)發佈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.